ACHE and dementia: The current first-line drugs for treating dementia, acetylcholinesterase (AChE) inhibitors, are designed based on the cholinergic hypothesis and work by increasing ACh levels in the synaptic cleft to improve cognitive function (Krall et al., 1999).